Item no. |
TRC-M203560-10g |
Manufacturer |
Toronto Research Chemicals
|
CASRN |
71-58-9 |
Amount |
10 g |
Quantity options |
100 g
10 g
1 g
25 g
50 g
50 mg
|
Category |
|
Type |
Biochemicals |
Specific against |
other |
Purity |
98% |
InCHI |
1S/C24H34O4/c1-14-12-18-19(22(4)9-6-17(27)13-21(14)22)7-10-23(5)20(18)8-11-24(23,15(2)25)28-16(3)26/h13-14,18-20H,6-12H2,1-5H3/t14-,18+,19-,20-,22+,23-,24-/m0/s1 |
Smiles |
O=C1CC[C@@]2(C)C([C@@H](C)C[C@]3([H])[C@]2([H])CC[C@@]4(C)[C@]3(CC[C@]4(OC(C)=O)C(C)=O)[H])=C1 |
ECLASS 10.1 |
32160490 |
ECLASS 11.0 |
32160490 |
UNSPSC |
12000000 |
Alias |
6alpha-Methyl-3,20-dioxopregn-4-en-17-yl acetate; Medroxyprogesterone acetate; Megestrol Acetate Imp. A (EP); Amen; Aragest; Aragest 5; Asconale; CBP 1011; Clinofem; Clinovir; Colirest; Curretab; Cycrin; DMPA; Depo-Clinovir; Depo-Prodasone; Depo-Provera; Depo-Ralovera; Depo-SubQ Provera 104; Depo-progestin; Depo-promone; Depomedroxyprogesterone acetate; Depot-medroxyprogesterone acetate; Farlutal; Farlutin; G-Farlutal; Gestapuran; Hematrol; Hysron; Indivina; Lutopolar; Lutoral; MAP; MAP (steroid); MPA; MPA Gyn 5; Med-Pro; Medroprogesterone acetate; Medroxyprogesterone 17-acetate; Meprate; Metigestrona; NSC 21171; NSC 26386; Nadigest; Nidaxin; Novo-Medrone; Oragest; Perlutex; Perlutex Leo; Prempack C; Prodasone; Progespon; Progestalfa; Progeston; Progevera; Provera; Proverone; Ralovera; Repromap; Repromix; Sirprogen; Sodelut G; U 8839; Veramix; Pregn-4-ene-3,20-dione, 17-(acetyloxy)-6-methyl-, (6alpha)-; Pregn-4-ene-3,20-dione, 17-hydroxy-6alpha-methyl-, acetate (7CI,8CI); Progesterone, 17-hydroxy-6alpha-methyl-, acetate (6CI); (6alpha)-17-(Acetyloxy)-6-methylpregn-4-ene-3,20-dione; 17alpha-Acetoxy-6alpha-methylpregn-4-ene-3,20-dione; 17alpha-Acetoxy-6alpha-methylprogesterone; 17alpha-Hydroxy-6alpha-methyl-4-pregnene-3,20-dione 17-acetate; 17alpha-Hydroxy-6alpha-methylpregn-4-ene-3,20-dione acetate; 17alpha-Hydroxy-6alpha-methylprogesterone acetate; 6alpha-Methyl-17-acetoxyprogesterone; 6alpha-Methyl-17R-hydroxyprogesterone acetate; 6alpha-Methyl-17alpha-Hydroxy-4-pregnene-3,20-dione acetate; 6alpha-Methyl-17alpha-acetoxy-Delta4-pregnene-3,20-dione; 6alpha-Methyl-17alpha-acetoxypregn-4-ene-3,20-dione; 6alpha-Methyl-17alpha-hydroxyprogesterone acetate; Megestrol Acetate Impurity A |
Available |
|
Mol. Weight |
386, 52 |
Country of Origin |
Canada |
IUPAC |
[(6S, 8R, 9S, 10R, 13S, 14S, 17R)-17-acetyl-6, 10, 13-trimethyl-3-oxo-2, 6, 7, 8, 9, 11, 12, 14, 15, 16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate |
Storage Condition |
4 |
Shipping Condition |
RT |
Shipping Info |
Not a Dangerous good |
Hazardous Class |
Suspected of causing cancer |
Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.
All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.